iSpecimen Inc. announced that the Company has recently expanded its global provider network to help advance women's health research. These strategic collaborations significantly expand the availability of high-quality tissue and biofluid specimens for studies on cervical, uterine and breast cancers; reproductive health; cardiovascular disease; autoimmune disorders and STIs. Among the new providers, one partner spans five sites in Ohio, Texas and Mississippi, which will help to unlock access to specimens from approximately 640,000 patients.

These specimens encompass a comprehensive range of samples, including tumor tissues, adjacent normal tissues, plasma, whole blood, bone marrow, urine, stool, peripheral blood mononuclear cells (PBMCs), hematopoietic stem cells, immune cells, buffy coat and serum. iSpecimen's expanded provider network also lends crucial support for reproductive research, with a significant pool of pregnancy donors under age 35, including those in their third trimester, along with urine samples from Cepheid GeneXpert CT/NG PCR tests. The iSpecimen Marketplace platform offers precise customization, allowing researchers to specify patient age, gender, race, condition, severity, blood type, treatment status, test results, outcomes, smoking status, family history and more.

Comprised of over 230 providers, iSpecimen's global biospecimen provider network offers researchers access to clinically collected samples, banked tissues, biofluids and prospective collections from diverse female populations.